Literature DB >> 1416374

Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.

G K Ogilvie1, M J Fettman, V J Jameson, L M Walters, M H Lafferty, M F Cooper, B E Powers, P A Ciekot, S W Atwater, S J Withrow.   

Abstract

A study was undertaken to determine the toxic effects of cisplatin, an antineoplastic agent, when administered immediately after a 1-hour saline diuresis. Four treatments with cisplatin (70 mg/m2 of body surface, q 3 wk) were administered IV to 6 healthy dogs over a 20-minute period after 0.9% NaCl (saline) solution was administered IV for 1 hour at a volume of 132 ml (kg)0.75. Each dog vomited at least once within 8 hours after each treatment was administered. Clinical status, body weight, and food consumption were normal throughout the 12-week study for 5 of the 6 dogs. The sixth dog developed acute renal failure and became acutely blind and deaf within 3 days after the fourth treatment with cisplatin. Serum electrolyte, creatinine, and urea nitrogen values remained within established normal limits in all dogs immediately prior to each treatment, and in 5 of 6 dogs evaluated 3 weeks after the final treatment. The serum creatinine value (3.3 mg/dl) obtained from the Beagle euthanatized 2 weeks after the fourth treatment was above established normal values. Despite normalcy for all but 1 of the creatinine values, serum creatinine concentration obtained 3 weeks after the final treatment with cisplatin was significantly (P = 0.0001) higher than pretreatment values. When compared with data from all other evaluation periods, significant decreases in glomerular filtration rate, as determined by exogenous (P less than or equal to 0.0001) and endogenous (P less than or equal to 0.0001) creatinine clearance testing, were identified 3 weeks after the fourth treatment with cisplatin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416374

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status.

Authors:  Dashti Rahmat Abadi Fatemeh; Hasan Ebrahimi Shahmabadi; Anita Abedi; Seyed Ebrahim Alavi; Fatemeh Movahedi; Maedeh Koohi Moftakhari Esfahani; Tahereh Zadeh Mehrizi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-07-23

2.  The influence of very low doses of Cisplatin on tumor cell proliferation in vitro and on some hematological and enzymatic parameters of healthy rats.

Authors:  Elzbieta Malarczyk; Martyna Kandefer-Szerszeń; Anna Jarosz-Wilkołazka
Journal:  Nonlinearity Biol Toxicol Med       Date:  2003-01

3.  Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration.

Authors:  Hannah Kenward; Ludovic Pelligand; Jonathan Elliott
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.